The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Q3 2015 Review with VBI Vaccines Inc. - Discusses Vaccine Development for Congenital CMV Infections

In this SNNLive On-Location, our host caught up with Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ: VBIV) in New York City, NY.

Share With

Wednesday, September 30, 2015

   

© 2017 Stock News Now